- Approval Id
- 74f2b13362b38dd4
- Drug Approval Philippines Name
- M-M-R II
- Product Name
- M-M-R II
- Registration Number
- BR-917
- Brand Name
- M-M-R II
- Generic Name
- Measles, Mumps and Rubella Vaccine (Live,
Attenuated)
- Dosage Form
- Lyophilized Powder for Solution for Injection (IM/SC)
- Dosage Strength
- REMARKS:
Formulation:
After reconstitution, each dose (0.5 mL) contains:
Live, attenuated virus derived from Edmonston B strain of measles………………… 3.0 log TCID50*
Live, attenuated Jeryl Lynn strain of mumps…………..4.1 log TCID50*
Live, attenuated Wistar RA27/3 strain of rubella. …………3.0 log TCID50*
*TCID 50 - Tissue Culture Infectivity Dose 50%
- Manufacturer
- Merck Sharp and Dohme LLC
- Importer
- Merck Sharp & Dohme (I.A.) LLC
- Distributor
- Merck Sharp & Dohme (I.A.) LLC
- Issuance Date
- 26 April 2023
- Expiry Date
- 26 January 2028
- Classification
- Prescription Drug (RX)
